RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 120 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $310,000 | +84.5% | 84,600 | +11.9% | 0.02% | +56.2% |
| Q2 2016 | $168,000 | -74.6% | 75,600 | -76.3% | 0.02% | -76.1% |
| Q1 2016 | $662,000 | -31.4% | 318,700 | 0.0% | 0.07% | -45.5% |
| Q4 2015 | $965,000 | +25.7% | 318,700 | +2.0% | 0.12% | +23.0% |
| Q3 2015 | $768,000 | +46.3% | 312,500 | +90.8% | 0.10% | +37.0% |
| Q2 2015 | $525,000 | -10.1% | 163,800 | 0.0% | 0.07% | -11.0% |
| Q1 2015 | $584,000 | +889.8% | 163,800 | +525.2% | 0.08% | +720.0% |
| Q4 2014 | $59,000 | – | 26,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |